Sex differences in diet-induced regulation of non-exercise activity thermogenesis in overweight and obese adults by Arcon, Matevz
Sex differences in diet-induced regulation of non-
exercise activity thermogenesis in overweight and 
























I, Matevz Arcon, hereby certify that this thesis submitted in partial fulfilment 
of the requirements for the award of Masters by Research (MbR), Abertay 
University, is wholly my own work unless otherwise referenced or 
acknowledged. This work has not been submitted for any other qualification 
at any other academic institution. 
 
Signed [candidates signature]…………………………………………………. 
Date……………………………………………………………………………….. 
 
Supervisor’s declaration:  
 
I, [insert Principal Supervisors name] hereby certify that the candidate has 
fulfilled the conditions of the Resolution and Regulations appropriate for 
the degree of [XXXXXXX] in Abertay University and that the candidate is 
qualified to submit this thesis in application for that degree. 
 
Signed [Principal Supervisors signature]……………………………………... 
Date……………………………………………………………………………….. 
 
Certificate of Approval 
I certify that this is a true and accurate version of the thesis approved by 









I must express my gratitude to quite a lot of people who supported/helped 
me throughout my undergraduate study until the end of this MbR. 
Especially, I would like to thank my supervisors who have spent a 
substantial amount of time and energy in giving me precious advice while 
also keeping me on the righteous path. I know I was not the easiest student 
to supervise and that is why I must thank you twice!  
Second, I have to thank all the participants who went through this tough 
dietary intervention so I could write-up my masters thesis. Your help was 
paramount as without it, I would have no study to write now. Lastly, I would 
like to thank Andrea Cameron and Abertay University for sponsoring my 
MbR with the Abertay Futures Scholarship. I arrived at this university as a 
failed computer scientist and I am now leaving with a BSc(hons) in Sport 
and Exercise Science and (hopefully) an MbR in the same field. Thank you 








Introduction: Reductions in physical activity energy expenditure (PAEE) 
and basal metabolic rate (BMR) have been proposed as factors that may 
hinder diet-induced body mass loss. Although diet-mediated changes in 
PAEE and BMR are subject to large inter-individual variability, research 
investigating the impact of sex on diet-induced modulation of PAEE and 
BMR is lacking. Therefore, this study examined the effect of a diet-induced 
energy restriction on PAEE and BMR in non-exercising individuals with 
overweight and obesity. Methods: Eleven women (Age: 25 ± 7 yr; BMI: 
29.7 ± 4.2 kg/m2) and eight men (Age 29.6 ± 4.0 yr; BMI: 29.7 ± 4.0 kg/m2) 
completed a 29-day investigation. Assessment of PA (PAEE and step 
count), BMR, body mass, systolic blood pressure (SBP), diastolic blood 
pressure (DBP) and fasting blood glucose (BG) occurred on days 1, 8, 15, 
22 and 29. Between day 15 and day 22, participants consumed a liquid diet 
formula equivalent to 50% of their total daily energy expenditure. The 
effects of time, sex and their interaction on all variables were assessed 
through a two-way mixed model ANOVA. Results: Both men and women 
achieved a modest 3% body mass loss at the end of the intervention week. 
An effect of time was detected for body mass (p<0.001), BMI (p<0.001), 
body fat % (p=0.001), SBP (p=0.007), DBP (p=0.033) and BG (p<0.001). 
There was a time and sex interaction in both males and females for body 
mass (p=0.002), BMI (p=0.002) and body fat % (p=0.043). Sex differences 
were only present for body fat % (p=0.001) and BMR (p<0.001). No main 
or interaction effects were present for PAEE and step count. Conclusion: 
A 7-day diet-induced energy restriction of 50% may be a viable short-term 
strategy to produce initial reductions in body mass and body fat %, and 
improvements in fasting blood glucose and resting blood pressure with no 
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Obesity is a complex and multifactorial disease characterised by abnormal or 
excess body fatness which is associated with several pathological conditions 
such as hypertension, type 2 diabetes and certain forms of cancer (Hruby and 
Hu, 2014). In addition, the increasing worldwide prevalence of obesity is now 
recognised to be a major economic burden to national health care systems due 
to its close association with other comorbidities (Ng et al. 2014). Although the 
aetiology of obesity is not entirely understood, genetic and environmental factors 
contribute considerably to the increasing incidence of obesity in Western society 
(Castillo et al. 2017; Hall 2017). For example, genetic differences account for 50-
70% of the divergence in body mass within the population (Locke et al. 2015). 
However, because our genome has remained relatively unchanged in the last few 
decades (Castillo et al. 2017), it has been suggested that modernisation has led 
to the creation of an obesogenic environment which favours physical inactivity 
and consumption of energy dense food (Hall 2017).  Put simply, body mass gain 
and obesity are caused by a prolonged state of positive energy balance, where 
energy intake (EI) exceeds energy expenditure (EE) (Romieu et al. 2017). By 
contrast, to induce body mass loss, a state of negative energy balance (i.e. EE 
exceeds EI) must be elicited over weeks or even months (Hall et al. 2012). 
Importantly, within people with overweight or obesity populations a clinically 
significant 5% reduction in body mass is known to elicit positive effects such as 
reduced hypertension, improved blood glucose control and lower risk of 
cardiovascular disease and certain cancers (Rueda-Clausen, Ogunleye and 
Sharma 2015).  
1.1 Formula based diets and changes in body composition 
At energy balance, variations in body mass are largely attributable to changes in 
water content of fat-free mass (Bhutani et al. 2017). By contrast, energy 
restriction (ER) results in further changes in body stores which are largely 
responsible for the rapid decrease in body mass (Yoo 2018). For example, very-
low energy diets (VLED) and low energy diets (LED) are formula based liquid 
diets that provide less than 800kcal/day and 800-1200kcal/day, respectively, and 
are enriched with micronutrients, essential fats and fibre (Lean 2011). These 
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types of diets are believed to be efficacious as a result of several interconnected 
mechanisms. First, they involve the substitution of conventional/solid food with 
defined portions, therefore, a higher degree of compliance can be ensured for 
those in which portion control is problematic (Harper et al. 2018). Second, in 
comparison to solid/conventional foods, greater energy deficits can be induced 
using enriched formulas whilst avoiding potential nutrient deficiencies (Lean 
2011).  
During the first phase of ER (up to 28 days), the rapid increase of insulin 
sensitivity coupled with decreased hepatic glucose output induces natriuresis and 
reduction in extracellular water, which results in a rapid decrease of body mass 
(Yoo 2018). Noteworthy, during this initial phase of body mass loss, a greater 
decrease of fat-free mass than fat mass is found (Müller et al. 2015). This loss of 
body protein occurs due to negative nitrogen balance, but initially results more 
prominently from gastrointestinal tract and liver proteins involved in nutrient 
processing (Hopkins and Blundell 2016; Carbone, McClung and Pasiakos 2012).  
Subsequently, proteolysis occurs in the skeletal muscle and other visceral organs 
(Yoo 2018). Ultimately, the combined effect of glycogen, body protein and fluid 
loss largely contribute to the rapid reduction in body mass which is often observed 
in the first phase of VLED or LED (Bhutani et al. 2017).  
1.2 Energy restriction and metabolic adaptations to body mass loss 
Total daily energy expenditure (TDEE) is comprised of several components 
namely basal metabolic rate (BMR), thermic effect of food (TEF) and physical 
activity energy expenditure (PAEE) (Müller et al. 2016). In inactive individuals, 
BMR accounts for 60-70% of TDEE and can be defined as the EE required for 
homeostatic processes (Villablanca et al. 2015), whereas TEF is the EE related 
to the digestion and storage of food which accounts for approximately 10% of 
TDEE (Hall et al. 2012). PAEE can be furtherly divided into two subgroups namely 
exercise activity thermogenesis (EAT) and non-exercise activity thermogenesis 
(NEAT). The former, EAT, represents the energy expenditure yielded from 
volitional exercise and is estimated to account for between 15-30% of the TDEE 
(Westerterp 2017). By contrast, NEAT is the energy cost of non-volitional 
exercise related activities such as spontaneous physical activity (SPA), but also 
other habitual activities like maintenance of body posture, ambulation and 
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fidgeting, and can account for up to 50% of the TDEE in highly-active individuals 
(Westerterp 2016; Levine 2004; Levine 2002).  
When EAT is not accounted for due to lack of volitional exercise, NEAT 
accounts entirely for the changes in PAEE. Often, however, interventions 
adopting diet-induced ER alone report body mass losses 12-44% lower than 
predicted (Yoo 2018). This is because energy balance is a non-linear (dynamic) 
process, and an attempt to reduce EI often results in an unintended change in 
one or more components of TDEE to prevent starvation, and potentially death, 
thus ultimately altering the rate of body mass loss (Romieu et al. 2017). Indeed, 
when ER is induced, the initial body mass loss is accompanied by metabolic and 
behavioural changes that manifest primarily in BMR and PAEE (Piaggi 2019). For 
example, Doucet, Pomerleau and Harper (2004) showed that 4 days of diet-
induced ER (800kcal/day) caused a decrease in BMR (-43kcal/day) in 15 
overweight men. Similar findings were reported in a more recent study on obese 
men and women by Nymo et al. (2018), where similar reductions in BMR (-
48kcal/day) were observed after 3 days of ER using a LED which provided 
670kcal and 550kcal/day for men and women, respectively.   
Disproportionate changes have been observed when BMR was separately 
analysed for biological sex. In fact, after adjusting for fat-free mass (FFM) and fat 
mass (FM), 3 days of ER produced a 24kcal/day greater decrease of BMR in 
women than in men.  Moreover, an in-patient study on non-obese men, showed 
a significant decrease in BMR (-70kcal/day) after just 3 days of 50% diet-induced 
ER (Müller et al. 2015). They also observed further decreases in BMR after 7 
days of sustained ER. Nevertheless, this drop in BMR started to plateau after 21-
days, when a 5% reduction in body mass was achieved. Potentially, the greater 
drop in BMR at the 3-day mark could be explained by study design, which 
involved 7 days of overfeeding at 50% above maintenance calories prior to 
dieting. Interestingly, a systematic review by Schwartz and Doucet (2010) 
examined changes in BMR during diet-induced ER. Although they reported 
similar decreases in BMR for both sexes, their findings might not be applicable to 
the first phase of ER as only trials that lasted more than 2 weeks were included 
in their analysis.  
In addition to its effects on BMR, diet-induced ER also appears to have an 
impact on PAEE. For example, de Groot et al. (1989) showed that 4 weeks of 
 
4 
50% ER though diet resulted in a 4-11% reduction in BMR and was accompanied 
by concomitant decreases in PAEE, which almost entirely explained the collective 
drop in TDEE (-274kcal/day). Similarly, Heyman et al. (1992) induced a 20% ER 
via diet, which after 20 days resulted in reduced BMR and PAEE of 99kcal/day 
and 198kcal/day, respectively. Comparable findings were observed in longer 
term trials. For example, Camps, Verhoef and Westerterp (2013) reported a 
220kcal/day decrease in PAEE after 8 weeks of LED (500kcal/day) in obese men 
and women. Nonetheless, PAEE returned to baseline when energy balance was 
re-established.  
In a randomised control trial of 105 adults, Martin et al. (1985) used doubly-
labelled water and accelerometery, a gold-standard combination technique, to 
assess the effects of 10% and 30% ER on PAEE. Although biological sex and 
age were not found to be associated with the effect of ER on PAEE, a 200kcal/day 
reduction in PAEE was observed after 12 weeks of 30% ER. Similar findings were 
reported by Weigle et al. (1988) where they showed that body mass loss elicited 
a 29% reduction in TDEE. Although BMR accounted for only 8% of the total 
reduction, PAEE explained the remaining 21% drop in TDEE. Moreover, in their 
‘weight clamping’ experiment, Liebel, Rosenbaum and Hirsch (1995) observed a 
15% decrease in TDEE with underfeeding in obese women, and participants were 
not taking part in any volitional exercise, changes in TDEE were believed to be 
largely attributed to changes in PAEE. Similarly, Racette and colleagues (1995) 
showed reductions in BMR and PAEE which accounted for a 350kcal/day drop of 
TDEE after 12 weeks of diet-induced ER.  
Even when compared to exercise, diet-induced ER provoked the greatest 
compensation in PAEE. In a study where ER was induced either via diet alone, 
diet plus low-intensity exercise or diet plus moderate intensity exercise, the 
greatest compensation in PAEE (-30%) was observed in the diet-only group 
(Wang et al. 2008). Moreover, the magnitude of body mass regain in this study 
was greater in participants who experienced larger reductions in TDEE during 
ER. Decreases in PAEE were also reported in a study by Martin et al. (2007), 
where 12 weeks of 25% diet-induced ER and LED (890kcal/day) yielded 12% 
and 20% drops in PAEE, respectively. Taken together, components of TDEE, 
particularly BMR and PAEE, change in response to perturbations of energy 
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balance. However, these changes were more pronounced during the first phase 
of ER (Yoo 2018).  
Adaptations to ER, dictated by hormonal and metabolic changes, result in 
reduced sympathetic nervous activity tone, decreased leptin and 
triiodothyronine (T3) production and increased skeletal muscle efficiency, which 
in turn limit body mass loss and predispose for future body mass regain 
(Rosenbaum and Leibel 2010). The magnitude of these hormonal and metabolic 
adaptations seems to depend on the phenotypic profile of an individual (Piaggi 
2019). For example, ‘spendthrift’ phenotypes show greater increases in TDEE 
during overfeeding and have smaller reductions in TDEE while fasting. By 
contrast, ‘thrifty’ phenotypes are more resilient to increases in TDEE during 
overfeeding but are more likely to reduce TDEE in response to fasting (Piaggi 
2019). This is very significant, as an increasing body of evidence suggests that 
faster rates of initial body mass loss, and hence higher sustained EE, is positively 
associated with successful body mass loss and long-term maintenance (Nackers, 
Ross and Perri 2013). Moreover, men have been shown to display greater 
reductions in body mass than women, even after adjustment for differences in 
body mass percentage (Fogelholm et al. 2017). Therefore, this may suggest a 
greater prevalence of thriftiness in women than in men. To the knowledge of the 
investigator, there is a paucity of research examining the sex-mediated 
differences of PAEE and BMR in response to diet-induced ER (Yoo 2018). 
1.3 Aims and hypothesis 
The aim of this study was to investigate whether 7 days of diet-induced ER had 
an effect on PAEE, and BMR in overweight and obese men and women. It was 
hypothesised that acute diet-induced ER would result in lowered BMR and PAEE, 
and that this compensatory response would be relatively greater in women than 





2.1 Experimental design 
This study used a time series design, with an initial 2-week control period to 
investigate the effect of 1-week of diet-induced ER (50% of TDEE) on PAEE and 
BMR in overweight and obese men and women. Participants visited the 
institution’s laboratory on five separate occasions over four weeks (i.e. 2-week 
control period before the intervention, 1-week of intervention and 1-week after the 
intervention). The five visits to the lab occurred on study days 1, 8, 15, 22 and 29 
for assessment of body composition, fasting blood glucose, blood pressure and 
BMR. The 7-day time period between each visit to the laboratory was selected to 
match the time frame of the liquid-based diet intervention and the usual time used 
to assess physical activity in the free-living (Levine 2002). Consequently, this 
study used hip and wrist-worn tri-axial accelerometers to determine total amount 
of steps and PAEE that were measured in 7-day blocks between study days 1 
and 29 and 8 and 29, respectively (see Figure 1).  
 
 
Figure 1: Study timeline overview. Grey shaded area represents the control period used to 
assess PAEE Study days 1, 8 and 15 were used to determine baseline values before the 
intervention. 
2.2 Participants 
A total of 25 adults with overweight or obesity volunteered to participate in the 
study. Six participants (4 men and 2 women) withdrew from the study prior to 
completion. Two men dropped out of the study because they were unable to visit 
the laboratory on the designated assessment days. Two women and two men 
withdrew from the study due to nausea from the liquid diet. Therefore, a total of 
11 women and 8 men completed the study and were included in the data analysis.  
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The recruitment process was carried out via social media, word of mouth 
and leaflets, which were placed on notice boards of the Abertay University 
campus. Participants were eligible to participate if they satisfied the following 
criteria: 1) aged between 18 and 40 years; 2) body mass index (BMI) between 25 
and 40 kg/m2; 3) engage in ≤ 1 session of volitional exercise per week. The 
inclusion criteria were determined to limit potential confounding factors. Total 
daily energy expenditure (TDEE) and PAEE both increase during the first two 
decades of life, however, plateau between 17 and 40 years of age and tend to 
decline after the age of 40 (Manini 2010). Second, there seems to be a divergent 
response in regulation of PAEE due to ERbetween normal weight and 
overweight/obese, but not between overweight and obese (Ravussin 2005). 
Furthermore, because negative energy balance can transiently alter BMR and 
PAEE, volunteers who had attempted volitional body mass loss via reduction of 
EI and/or increased weekly bouts of structured exercise (more than one bout of 
exercise per week) one month prior to taking part in the study were excluded. 
This was verbally verified on the first laboratory visit via self-reporting.  
Although the target sample size (10 men and 10 women), which reflected 
group sizes in previous trials, was not achieved due to drop-outs, the final sample 
size was set based upon the logistical limitations of the research project, and 
comparable to other trials investigating changes in PAEE in the free living (Leibel, 
Rosenbaum and Hirsch 1995; Levine 1999). Prior to commencing the study, all 
participants were fully informed both verbally and in writing about the study and 
then given a period of 7 days to decide whether to participate  in the study. A 
written informed consent and completed a Physical Activity Readiness 
Questionnaire (PARQ) to ensure there were no underlying health issues. The 
study was approved by the Abertay University School of Health and Social 
Sciences Ethics Committee (EMS1014) and all experimental procedures were 
carried out in accordance with the World Medical Association Declaration of 
Helsinki (Emanuel 2011). Participants’ personal information was kept confined 
within the study by using coded aliases and password protected files to ensure 
compliance with GDPR policies (Voigt and Von dem Bussche, 2017).  
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2.3 Preparation for laboratory visits  
To ensure consistency between measurements, participants visited the 
laboratory between 7am – 9am following an overnight fast. The overnight fast 
consisted of avoiding consumption of food, caffeine, nicotine and any caloric 
beverage 12 hours prior to testing but allowed water ad libitum (Lopes, Chaia and 
de Brito 2013). Furthermore, participants were asked to avoid taking part in 
vigorous exercise 24 hours prior to testing to ensure accurate measurement of 
BMR (Edwadson and Gorely, 2010). Upon arrival, participants were asked to void 
prior to commencing testing (Fernández-Verdejo, Aguirre and Galgani 2019). 
Compliance was verified by the investigator on the testing day by participants’ 
verbal self-reporting.  
These criteria were required to gather an accurate analysis of BMR, body 
composition, blood pressure and fasting blood glucose (Hunt and Hellwig 2018; 
Kesavadev et al. 2014). For instance, analysis of BMR via indirect calorimetry is 
subject to change in reflection to nutritional status (Fernández-Verdejo, Aguirre 
and Galgani 2019). In fact, the impact which TEF has on BMR is largely variable 
and depends on the magnitude of the EI macronutrient ratio (Westerterp 2004).  
Other potential confounding variables such as caffeine and nicotine intake 
can also affect BMR and blood pressure via augmented catecholamine release, 
which may translate in raised heart rate and increased fatty acid mobilisation 
(Lafontan and Langin 2009; Versmold 1991). 
Vigorous exercise performed 24-hours prior to analysis can also transiently 
increase BMR. In fact, BMR has been shown to increase transiently by up to 
approximately 300kcal/day following a bout of resistance exercise training mainly 
due changes in body temperature, lactate clearance and muscle protein 
synthesis (Laforgia, Withers and Gore 2006). This acute exercise-induced 
increase in BMR is due to excess post-exercise oxygen consumption (EPOC) 
and is mainly driven by intensity of exercise (Borsheim and Bahr 2003).  
2.4 Anthropometry 
During day 1 only, stature was measured to the nearest 0.1 cm using a 
stadiometer (SECA 216, SECA, Hamburg, Germany). Participants stood without 
shoes with their heels together, back against the plastic cover and arms by their 
side. The head was erect and in the Frankfort horizontal plane) (Bryant and Green 
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2012). The stadiometer moveable head plate was then lowered to the top of the 
head at which point the participant was asked to breathe in deeply. The 
measurement was recorded just before the participant exhaled (Bryant and 
Green 2012).  
The remaining anthropometric variables were measured during all laboratory 
visits. To ensure an accurate and consistent reading of body composition via the 
leg-to-leg bioelectrical impedance scale (SC-330ST, Tanita Europe, Amsterdam, 
the Netherlands), participants were asked to void  and then remove excess 
clothing (i.e. jacket, jumper) just prior to recording body mass (kg) and body fat 
(%) (Fernández-Verdejo, Aguirre and Galgani 2019). The participant stepped 
barefoot on the analyser’s footpads and minimised movement until analysis was 
completed. In line with the Tanita guidelines for body type assessment, which 
due to the weekly activity level deemed the participants as non-athletic, body type 
analysis was set to standard adult mode (Franco-Villoria et al. 2016). Participants’ 
chronological age and stature were entered and output values for body mass (kg) 
and body fat (%) measured to the nearest 0.1 respective unit. Ultimately, body fat 
(%) was determined using two electrodes located on the analyser’s footpads 
which send an imperceptible electrical current through the body (50 kHz 
alternating current of 800μA between electrodes). The impedance value (Z) 
reflects the resistance and reactance which the electrical signal encounters when 
passing through the body; and because the ionised fluid in lean body mass acts 
as a conductor, differentiation between lean body mass and fat mass can be 
determined (Lemos and Gallagher 2017). In addition, accurate analysis of body 
composition using a two-compartment model technique (i.e. bioelectrical 
impedance) is highly dependent on changes in hydration level and nutrition status 
(glycogen content and presence of food in the digestive system) (Lemos and 
Gallagher 2017). This is because bioelectrical impedance predicts body 
composition based on the electrically conductive proprieties of fat free mass and 
fat mass. The latter is less conductive, however, due to its higher content of water 
and electrolytes, fat free mass is more conductive which in turn allows 
differentiation between tissues (Vasold et al. 2019). 
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2.5 Blood pressure 
Resting blood pressure as systolic blood pressure, diastolic blood pressure and 
pulse pressure, were recorded twice on the participant’s non-dominant arm using 
an automated oscillomettric blood pressure monitor (DSK-1031, Nissei 
Healthcare, Henfield, UK). Prior to commencing the test, all clothing covering the 
location of cuff placement was removed to prevent blood flow restriction. The first 
blood pressure measurement was taken after the participant was seated 
comfortably for 5 min, with the back supported, feet on the floor, arm supported 
in the horizontal position on a table, with the middle of the blood pressure cuff on 
the participant’s upper arm at the heart level. Both the participant and the 
investigator remained silent during the entire procedure. The second 
measurement was taken immediately after the first was completed, and the 
measurement with the lower pulse pressure was then used for analysis (Hunt and 
Hellwig 2018). 
 
2.6 Fasting blood glucose 
Fasting blood glucose was determined via fingertip blood samples (Freestyle Lite, 
Abbott Diabetes Care Inc., Alameda, USA). After the puncture site (tip of the 
index finger) had been wiped with alcohol swabs, the skin was punctured using 
an Accu-check single use lancet (Roche Diagnostics, UK) and pressure applied 
to the finger to draw the blood (Pickering and Marsden 2014). As recommended 
by the World Health Organisation (Dhingra 2010), the initial drop was discarded, 
and the second drop was taken for analysis.  
2.7 Basal metabolic rate  
In this study, BMR was determined by breath-by-breath analysis using an open-
circuit indirect calorimetry (MetaMax 3B, Cortex Biophysik, Leipzig, Germany) 
(Compher et al. 2006). The participant had to rest in a comfortable supine 
position, minimise movement and remain silent in quiet environment with soft 
lighting for 30 min. A silicone mask was fitted on the participant’s face and 
tightened to avoid air leakage. Whilst the participant was resting, full calibration 
of the metabolic cart was carried out in accordance to the manufacturer’s 
guidelines by the investigator. This comprised of volume calibration using a 3-litre 
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calibration syringe, pressure calibration with a digital barometer (Barometer 
GA690, Castle Group, UK) and gas calibration using a 1.2 litre bottle with 15% 
oxygen (O2), 5% and carbon dioxide (CO2), in nitrogen (N2). After the metabolic 
cart had been calibrated, BMR was measured for 15-20 minutes and the average 
VO2 and VCO2 values from the last 10 minutes were used for analysis (Popp et 
al. 2016; Psota and Che 2013). This method was based on the systematic review 
by Compher et al. (2006) which determined the optimal conditions for obtaining 
reliable measures of BMR by indirect calorimetry. Due to its high prevalence in 
human studies, Weir’s equation with dismissed protein oxidation was used to 
calculate BMR (Fernández-Verdejo, Aguirre and Galgani 2019). 
 
 BMR (kcal/day) = (3.941 x VO2 (ml/min) + (1.106 x VCO2 (ml/min)) x 1.44)( Popp 
et al. 2016) 
 
2.8 Physical Activity Indices  
Step count, was measured from day 1 to day 29 of the study using a tri-axial 
accelerometer (Mi Band 3, Xiaomi, Beijing, China) which had an embedded heart 
rate sensor, and was worn on the wrist of the dominant arm The first iteration of 
this activity tracker has been shown to be an accurate and valid alternative to 
more costly accelerometers which are already validated in clinical research (El-
Amrawy and Nounou 2015). For this study, heart rate sampling frequency (Mi 
Band 3, Xiaomi, Beijing, China) was set to 60 s via the Android application Mi Fit 
(Xiaomi, Beijing, China).  
To measure PAEE, participants wore a second tri-axial accelerometer 
(ActiGraph GT3X+, Florida, USA) on the right hip from study day 8 to study day 
29 (Sasaki, John and Freedson 2011). Participants were advised to wear the 
accelerometers continuously except during their sleep and activities which would 
submerge the accelerometers in water.  A day was considered valid only when 
the accelerometers were worn for at least 10 h between 0700 and 2300 
(LeCheminant et al. 2017). In addition, a phase (week) was considered valid only 
when it was comprised of four or more valid days (Migueles et al. 2017). The 
ActiGraph accelerometer was set-up with 60 s sampling epochs which were 
collected at a 30 Hz sample rate, and the Freedson VM3 combination algorithm 
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was used to estimate PAEE from the vector magnitude counts per min of the 
three axis (Brown et al. 2017). PAEE data from each phase was averaged and 
presented as kcal/day. The method for the ActiGraph GT3X+ accelerometer was 
based on the systematic review by Migueles et al. (2017) which provided practical 
considerations such as optimal placement, sampling frequency, epoch length and 




2.9 Diet-induced energy restriction  
The methods to assess TDEE require quantification of all its components, namely 
BMR, TEF and PAEE. To calculate participant’s average pre-intervention TDEE, 
BMR and TEF from study days 1, 8 and 15 were averaged and summed with 
daily average of PAEE from the Pre-intervention phase. TEF was assumed as a 
generic 10% value of TDEE (Kinabo and Durnin 1990):  
 
TEF(kcal/day) = (BMR + PAEE) x 0.1 
𝑇𝐷𝐸𝐸(𝑘𝑐𝑎𝑙/𝑑𝑎𝑦) = BMR +  TEF +  PAEE   
 
During the intervention period (study days 15 - 21), participants were given a 7-
day supply of the formula-based liquid diet (Meal Replacement, MyProtein, UK) 
which was purchased by the investigator and provided a macronutrient 
breakdown of 38% protein, 38% carbohydrates, 15% fats and 9% fibre (Nymo et 
al. 2018). Participants were asked to use the formula-based liquid diet as their 
only source of energy intake which resulted in a 50% energy restriction in relation 
to participants’ mean pre-intervention TDEE. The formula-based diet was 
weighed by the investigator using a commercially available kitchen scale (Salter, 
HoMedics Group Ltd, Kent, UK) and individually packaged to provide the exact 
energy value each day during the intervention period. No recommendation was 
given in regards to meal pattern or meal frequency. Participants could consume 
any very-low or non-caloric beverage such as black coffee, green tea or soft 
drinks with no added sugar (i.e. diet soda). 
2.10 Study compliance survey 
To gather insights regarding the rate of compliance to the study procedures, at 
the end of data collection an anonymous survey was sent to participants. The 
survey comprised of 4 closed questions which served to evaluate the dietary 
compliance to the liquid diet and participant’s conditions on each testing day (See 





2.11 Statistical analyses  
All statistical analyses were performed using the statistical package for the social 
sciences software for windows (SPSS 24.0, IBM, Chicago, IL, USA). All data were 
checked for normality using histograms and the Shapiro-Wilk test. Levene's and 
Mauchley's test were respectively used to check for homogeneity of variance and 
sphericity. When the latter was violated (p ≥ 0.05) the Greenhouse Geiser 
correction was used (Field 2018). A two-way (Time x Sex) mixed model ANOVA 
was used to assess the effects of time, sex and their interaction on all variables 
during the control period (except PAEE assessed by ActiGraph which only 
included 1 week of control) as well as across all periods (i.e. control, intervention 
and post-intervention). Pairwise comparisons were performed using the 
Bonferroni correction (Jackson 2015). As BMI was not normally distributed, an 
adjusted rank-transformation was applied to these data (Leys and Schumann 
2010). All data are presented as M±SD (95% confidence intervals: lower, upper) 
unless specified, and mean differences (MD) provided when significant main 
effects were found. Partial eta squared (ηp2) effect sizes were interpreted as 0.01 
small, 0.06 moderate and 0.14 as large whilst Cohen’s effect size (d) was defined 





3.1 Control period 
Of the 25 initially recruited volunteers, 8 men (age: 26 ± 4; BMI: 29.6±3.7) and 11 
women (age: 25 ± 7; BMI: 29.7 ± 4.1) completed the study. The control period 
served to evaluate the consistency of the measurements and to compare the 
physical characteristics between men and women (Table 1).  
The key findings are that there was a significant difference between men and 
women for body fat (F(1,17) = 16.007; MD =-10.833; 95% CI:-16.55 to -5.120; p 
< 0.001; d = 2.0) and BMR (F(1,17) = 13.633; MD =-347.594; CI: -546.139 to -
148.959 ; p < 0.002; d = 1.6). In addition, there was a main effect of time on body 
fat (F(2,34) = 4.674; p=0.027; ηp2=0.562) between day 1 and day 8 of the study 
(MD: -0.618; p=0.004; CI:-0.194 to 1.043). There was a significant main effect of 
time on lean body mass (F(2,34)=4.290; p=0.022; ηp2=0.201) between day 8 and 
day 15 of the study (MD:0.477; p=0.038; CI: 0.23 to 0.930). Moreover, 
significance was detected for the interaction between time and sex for lean body 
mass (F(2,34) = 1.134; p = 0.026; ηp2 = 0.194). Lastly, significance in lean body 
mass was also detected for sex (F(1,17) = 73.715; p < 0.001; MD =16.212; CI: 
12.228 to 20.196; d = 3.8). No other main or interaction effects were observed in 




Table 1. Anthropometric, metabolic and physiological measures during control 
period 
 
Day 1 Day 8 Day 15 Statistical significance of effect of: 
Variable Mean ± SD Mean ± SD Mean ± SD Time Sex Time x Sex  
Body mass (kg) 84.0 ± 13.3 83.8 ± 13.5 83.7 ± 13.5 0.373 0.061 0.504  
 Men 90.7 ± 13.5 90.6 ± 14.1 90.2 ± 14.3 / / /  
Women 79 ± 11.4 78.9 ± 11.1 78.9 ± 11.1 / / /  
BMI (kg/m2) 29.6 ± 3.7 29.6 ± 4.0 29.6 ± 3.9 0.912 0.726 0.390  
Men 29.6 ± 3.7 29.6 ± 4.1 29.5 ± 4.2 / / /  
Women 29.7 ± 4.1 29.6 ± 4.6 29.6 ± 3.9 / / /  
Body fat (%) 33.6 ± 7.9 33.0 ± 8.0 33.4 ± 7.8 0.027* 0.001* 0.290  
Men 27.4 ± 5.4 26.6 ± 5.7 27.3 ± 6 / / /  
Women 38.1 ± 6.3 37.8 ± 6 37.9 ± 5.5 / / /  
LBM (kg) 52.7 ± 9.1 53.1 ± 9.4 52.6 ± 8.9 0.022* <0.001* 0.026*  
Men 62.2 ± 5.7 62.7 ± 5.9 61.8 ± 5.9 / / /  
Women 45.9 ± 2.1 46.1 ± 2.3 46.1 ± 2.3 / / /  
BMR (kcal/24h) 1489 ± 293 1429 ± 257 1476 ± 284 0.232 0.002* 0.935  
Men 1685 ± 317 1627 ± 235 1686 ± 237 / / /  
Women 1347 ± 176 1285 ± 163 1323 ± 211 / / /  
BMR/kg(kcal/kg/24h) 17.8 ± 2.0 17.1 ± 2.0 17.7 ± 2.4 0.245 0.081 0.807  
Men 18.5 ± 0.9 18 ± 1.1 18.8 ± 1.4 / / /  
Women 17.2 ± 2.5 16.5 ± 2.3 16.9 ± 2.8 / / /  
SBP (mm Hg) 138 ± 23 135 ± 16 131 ± 18 0.068 0.108 0.252  
Men 148 ± 16 140 ± 13 138 ± 21 / / /  
Women 130 ± 25 132 ± 17 125 ± 15 / / /  
DBP (mm Hg) 82 ± 14 81 ± 11 28 ± 13 0.323 0.675 0.594  
Men 83 ± 9 80 ± 8 81 ± 18 / / /  
Women 81 ± 17 81 ± 13 76 ± 9 / / /  
PP (mm Hg) 71 ± 12 68 ± 8 69 ± 9 0.493 0.739 0.556  
Men 
71 ± 11 69 ± 8 71 ± 8 
/ / /  
Women 
71 ± 13 68 ± 8 67 ± 8 
/ / /  
BG (mmol/L) 4.5 ± 0.4 4.6 ± 0.4 4.5 ± 0.5 0.584 0.108 0.493  
Men 4.6 ± 0.5 4.7 ± 0.5 4.7 ± 0.5 / / /  
Women 4.4 ± 0.3 4.6 ± 0.4 4.3 ± 0.4 / / /  
BMI = body mass index, BMR = basal metabolic rate, BMR/kg = basal metabolic rate per kilogram of body mass, SBP = systolic 







Figure 2. Step count during control period 
 
Step count did not significantly change during the control period (F(1,15) = 0.376; 
p = 0.549; MD = 227; CI:-564 to 1019; ηp2 = 0.024 ). Moreover, no interaction 
between time and sex was detected for steps (F(2,34) = 0.407; p = 0.533; ηp2 = 
0.026 ). Lastly, there was no significant difference in the number of steps between 
men (9656 ± 2332 steps count) and women (7434 ± 2157 step count) (F(1,15) = 
2.985; p = 0.105; MD = 1984; CI:-463 to 4432; d = 1.2) at baseline.  
 
3.2 Entire study period 
3.2.1 Anthropometric and metabolic parameters with VLCD 
Due to the VLCD, there was a significant main effect of time on body mass 
(F(2,34) = 60.686; p < 0.001; ηp2 = 0.781) which resulted in a 3% body mass loss 
in both men and women. Significance was reached between control and day 22 
(MD = 2.855; p < 0.001; CI:2.190 to 3.520), control and day 29 (MD = 1.681; p < 
0.001; CI: 0.997 to 2.366), as well as between day 22 and day 29 (MD= -1.174; 
p = 0.001; CI: -1.897 to -0.450). There was a significant interaction between time 
and sex on body mass (F(2,34) = 7.368; p = 0.002; ηp2 = 0.302 ), however, no 
sex difference was detected ((F(1,17) = 3.646; MD = 10.725; CI: -1.125 to 22.575; 
p < 0.073; d = 0.87). For BMI, a significant main effect of time (F(2,34), p<0.001, 
ηp2=0.827) was reached between day control and day 22 (MD = 0.992; CI: 0.818 
to 1.167; p < 0.001), control and day 29 (MD = 0.562; CI: 0.333 to 0.792; p < 
0.001) as well as between day 22 and day 29 (MD = -0.430; CI: -0.645 to -0.215; 
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p < 0.001). Furthermore, an interaction effect between time and sex was present 
for BMI (F(2,34) = 7.684; p = 0.002; ηp2 = 0.827). Significance for time was also 
achieved for body fat (F(2,34) = 23.683; p < 0.001, ηp2 = 0.582). This significance 
was achieved between control and day 22 (MD = 1.204; CI: 0.750 to 1.658; 
p<0.001), control and day 29 (MD = 1.111; p = 0.001; CI: 0.469 to 1.1754), but 
no significance was observed between day 22 and day 29 (MD: -0.093; p = 1.000; 
CI: -0.520 to 0.335). Moreover, significance on body fat % was achieved for the 
interaction between time and sex (F(2,34) = 3.460; p = 0.043; ηp2 = 0.169) and 
for main effect of sex on body fat % (MD = 11.386; p = 0.001; CI: 5.512 to 17.260; 
d=1.9). A significant main effect of time was also observed for lean body mass 
(F(2,30) = 9.030; p = 0.001; ηp2 = 0.376) between control and day 22 of the study 
(MD = 1.030; p = 0.001; CI: 0.445 to 1.615) as well as between day 22 and day 
29 of the study (MD = -0.665; p = 0.028; CI: -1.265 to –0.065). Additionally, a sex 
difference for lean body mass was detected (F(1,15) = 63.325; MD = 15.053; p < 
0.001; CI: 11.021 to 19.068; d = 4.0), which is typical biological distinction 
between men and women.  
Significant main effect of sex was achieved for BMR (MD = 366; p < 0.001; 
CI: 191.111 to 540.831, d = 1.6). A main effect of time was also observed for SBP 
(F(2,34) = 5.727; p = 0.007; ηp2 = 0.252), however, only between control and day 
22 (MD = 8.835; p = 0.007; CI: 2.275). A significant effect of time was also 
detected for DBP (F(2,34) = 3.788; p = 0.033; ηp2 = 0.182), but only between 
control and day 29 of the study (MD = 4.780; p = 0.046; CI: 0.065 and 9.496). For 
pulse pressure, significant effect for interaction between time and sex was 
achieved (F(2,34) = 3.991; p = 0.028; ηp2 = 0.190).  
Lastly, a significant main effect of time of blood glucose (F(2,34) = 11.755; 
p < 0.001; ηp2 = 0.409) was reached between control and day 22 (MD = 0.358; p 
= 0.002: CI: 0.129 to 0.587) and day 22 and day 29 (MD = -0.586; p = 0.001; CI: 
-.0945 to -0.227). No other main or interaction effects were observed in the 




Table 2. Anthropometric, metabolic and physiological measures during entire 
study period.  
 
   Control    Day 22    Day 29 Statistical significance of effect of: 
Variable Mean ± SD Mean ± SD Mean ± SD Time Time x Sex Sex 
Body mass (kg) 83.9 ± 13.4 81.0 ± 12.9 82.3 ± 12.6 <0.001* 0.073 0.002*  
 Men 90.5 ± 14.0 87.4 ± 13.3 87.9 ± 13.6 / / /  
Women 78.9 ± 11.2 76.4 ± 10.9 78.2 ± 10.6 / / /  
BMI (kg/m2) 29.7 ± 4.0 28.6 ± 3.8 29.1 ± 3.7 <0.001* 0.873 0.002*  
Men 29.6 ± 4.0 28.6 ± 4.0 28.7 ± 3.9 / / /  
Women 29.7 ± 4.2 28.7 ± 4.0 29.4 ± 3.8 / / /  
Body fat (%) 33.4 ± 7.9 32.2 ± 8.3 32.3 ± 8.5 0.001* 0.001* 0.043  
Men 27.1 ± 5.7 25.6 ± 6.2 25.5 ± 6.7 / / /  
Women 37.9 ± 5.9 37.0 ± 5.9 37.3 ± 5.8 / / /  
LBM (kg) 52.3 ± 8.8 51.3 ± 8.6 52.1 ± 8.2 0.001* <0.001* 0.125  
Men 61.5 ± 5.8 60.3 ± 5.3 60.6 ± 5.1 / / /  
Women 45.9 ± 2.3 45.1 ± 2.4 46.1 ± 2.5 / / /  
BMR (kcal/24h) 1465 ± 264 1403 ± 265 1499 ± 312 0.164 <0.001* 0.828  
Men 1666 ± 263 1610 ± 206 1727 ± 259 / / /  
Women 1318 ± 183 1252 ± 193 1334 ± 238 / / /  
BMR/kg(kcal/kg/24h) 17.5 ± 1.9 17.4 ± 2.8 18.4 ± 3.7 0.211 0.067 0.573  
Men 18.4 ± 1.1 18.6 ± 2.2 20.0 ± 3.7 / / /  
Women 16.9 ± 2.5 16.6 ± 3.0 17.2 ± 3.4 / / /  
SBP (mm Hg) 135 ± 17 126 ± 16 130 ± 14 0.007* 0.086 0.737  
Men 142 ± 17 133 ± 19 135 ± 15 / / /  
Women 129 ± 19 120 ± 11 126 ± 14 / / /  
DBP (mm Hg) 80 ± 11 75 ± 8 75 ± 10 0.033* 0.225 0.183  
Men 82 ± 12 81 ± 10 76 ± 13 / / /  
Women 79 ± 13 71 ± 5 74 ± 8 / / /  
PP (mm Hg) 69 ± 7 69 ± 9 66 ± 9.6 0.183 0.058 0.028*  
Men 
70 ± 9 73 ± 6 72 ± 5 
/ / /  
Women 
69 ± 10 67 ± 10 61 ± 9 
/ / /  
BG (mmol/L) 4.5 ± 0.3 4.1 ± 0.3 4.7 ± 0.6 <0.001* 0.113 0.651  
Men 4.7 ± 0.5 4.3 ± 0.4 5.0 ± 0.7 / / /  
Women 4.4 ± 0.4 4.2 ± 0.3 4.6 ± 0.6 / / /  
BMI = body mass index, BMR = basal metabolic rate, BMR/kg = basal metabolic rate per kilogram of body mass, SBP = systolic 






3.2.2 Measures of PA 
Step count did not significantly change during the course of the study period 
(F(2,34) = 1.089; p = 0.348; ηp2=0.060). Moreover, no sex differences (F(1,17) = 
2.374; p = 0.142; d = 0.6), or interaction between sex and time (F(2,34) = 1.554; 
p = 0.226; ηp2 = 0.060) were detected. 
Similarly, PAEE did not reach significance for either time (F(2,34) = 1.528; p = 
0.231; ηp2=0.082), sex(F(1,17) = 1.771; p = 0.201; d = 0.6), or their interaction 
(F(2,34) = 0.396; p = 0.676; ηp2 = 0.023).  
 
Table 3. PA measures during entire study period 
 
Pre-Intervention Intervention    Follow-up Statistical significance of effect of: 
Variable Mean ± SD Mean ± SD Mean ± SD Time Sex Time x Sex  
Step count 8212 ± 2411 7539 ± 2677 8246 ± 2985 0.348 0.142 0.226  
 Men 9423 ± 2435 8824 ± 2330 8629 ± 3322 / / /  
Women 7332 ± 2070 6605 ± 2611 7968 ± 2848 / / /  
PAEE (kcal) 387 ± 166 343 ± 192 370 ± 213 0.231 0.201 0.676  
 Men 453 ± 196 418 ± 241 420 ± 279 / / /  
Women 339 ± 129 289 ± 134 333 ± 154 / / /  







3.2.3 Dietary compliance survey 
Out of the 19 participants who successfully finished the study, 14 of them 
completed the study compliance survey. The remaining 5 participants did not 
respond to our invitation to take part in the survey. This survey served to gather 
insights regarding participants’ compliance to the study procedures. The results 
showed that only one participant consumed and/or ingested energy dense foods 
or beverages, nicotine and/or alcohol prior to all 5 visits to the laboratory two 
participants reported that they were not able to consume all the given liquid diet 
formula. Two participants reported consumption of energy dense food and/or 
beverages which were not part of the liquid diet. It is noteworthy, however, that 






This study shows that a 7-day diet-induced ER of 50% of TDEE can reduce body 
mass and decrease fasting blood glucose levels and systolic blood pressure 
without eliciting detrimental changes in BMR, steps count and PAEE in both men 
and women.  
Significant body mass losses were observed after 7 days of diet-induced ER in 
both men (-3.1kg) and women (-2.5kg). Moreover, after adjusting for total body 
mass, body mass losses were identical and accounted for 3% of total body mass 
in both groups. These findings are in line with previous studies investigating body 
mass change in response to a similar diet (Nymo et al. 2018; Muller et al. 2015; 
Muller et al. 2016). Interestingly, at follow-up (i.e. 7 days after ad-libitum energy 
intake resumed), body mass changes became more divergent between men and 
women. In men, body mass regain was only 0.5kg whereas women experienced 
a threefold greater body mass regain, which amounted to 1.8kg. Because PAEE 
and steps count did not significantly differ between the two groups, a divergent 
response in post-starvation hyperphagia may explain the greater body mass gain 
observed in women (Dulloo, Jacquet and Girardier 1997). Indeed, volitional body 
mass loss and its maintenance seem to result in augmented fasting and post-
prandial appetite, which is mainly driven by alterations in hormonal regulators of 
appetite and can contribute to body mass gain (Perry and Wang 2012). Notably, 
in a recent review article investigating appetite changes following successful body 
mass loss, Hintze et al. (2017) suggested that although body mass loss results 
in increased fasting and post-prandial appetite, these changes do not seem to 
differ between men and women. Similar findings were reported in a short-term 
trial by Alajmi et al. (2016) where no divergent responses in appetite regulation 
between men and women were found after a single day of 800kcal ER. It is 
important to highlight, however, that Hintze et al. (2017) analysed only longer-
term trials (3+ weeks of ER) whereas Alajmi et al. (2016) investigated a single 
day of ER. This is paramount to consider because compensatory responses to 
alterations in energy intake may start to manifest with a 3 to 4-day lag (Bray et al. 
2008; De Castro 1998).  
Although in the present study, there were no significant differences in PAEE and 
step count, both PAEE (-44kcal) and step count (-673 steps) decreased during 
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the diet-intervention period. Interestingly, after 7 days of ad-libitum energy intake, 
only women recovered PAEE (-6kcal) and step count (+663 steps) to baseline 
values. By contrast, in men, PAEE (-33kcal) and step count (-793 steps) did not 
return to baseline values but rather, reduction continued during the 7 days of ad-
libitum energy intake. This divergent response between men and women in PAEE 
and step count during the post-intervention period may be partly explained by the 
different time period in which data collection was carried out; most of the female 
participants were recruited in spring, whereas most male participants were 
recruited in the beginning of summer. This may be an important confounding 
factor to consider as some evidence suggests that seasonal variations in physical 
activity, self-weighing behaviour and body mass management may have served 
as an incentive in the men’s group to maintain the body mass reduced state 
(Westerterp 2019; Fahey et al. 2019). If seasonal variation played a key role in 
body mass change after the diet intervention then analysis of BMR at follow-up 
(day 29) should have also shown a trend for decrease, however, that was not the 
case. In comparison to baseline, after 7 days of energy intake ad-libitum (day 29), 
men still had a greater BMR per kg of total body mass than women (+1.6kcal/kg 
vs +0.3kcal/kg) despite maintaining a state of reduced body mass (+0.5kg vs 
+1.8kg). Another possible explanation could be attributed to the protective role of 
a higher energy flux in men. Mounting evidence suggests that coupling a high 
energy intake to a high energy expenditure can aid maintenance of a reduced 
body mass state by fine-tuning appetite at higher energy expenditures (Melby et 
al. 2017). In the study, men had a consistently higher step count than women 
during control (+22%), diet-intervention (+25%) and post-intervention periods 
(+7%), which in turn might have resulted in a better appetite regulation after the 
diet-intervention (Hägele et al. 2019).  
In the present study, changes in BMR were assessed using indirect calorimetry 
before participants commenced the diet intervention (control period), immediately 
after the diet (day 22) and at follow-up (day 29). We observed a significant 
difference in BMR between men and women during the control period, but no 
difference was detected when BMR was adjusted per kilogram of body mass. 
Although BMR is determined by all metabolically active tissue, including the liver, 
brain and kidney, skeletal muscle has been shown to be main factors contributing 
to the metabolic discrepancy between men and women. In fact, this divergence 
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in BMR seems to furtherly dissipate after BMR is adjusted in proportion to LBM 
only (Bucholz, Rafii and Pencharz 2001). After the diet-induced ER (day 22), 
BMR decreased in both men and women by 56kcal and 66kcal, respectively. The 
observation that reductions in body mass led to a decrease in BMR has been 
extensively investigated (Melby et al. 2017). Schwartz and Doucet (2010) 
reported that for every kilogram of body mass that is lost, BMR decreases by 
approximately 15kcal, which largely explains the BMR drop observed in the study. 
This metabolic adaptation often persists after body mass loss, and in some cases 
can become permanent thus eliciting an energy gap (Melby et al. 2017). The latter 
can be defined as the discrepancy between energy requirements and appetite 
following successful body mass loss, which in turn promotes body mass regain 
(Fothgeril 2016; Camps, Verhoef and Westerterp 2013, Rosenbaum et al. 2008). 
It is important to highlight that manifestation of the energy gap is predominantly 
observed in longer-term studies where losses in body mass are more than 5% 
(Maclean et al. 2011). Interestingly, however, metabolic adaptations seem to be 
greater in magnitude during the first days of ER, mainly due to reduced insulin 
and leptin concentrations, intracellular water and glycogen content of skeletal 
muscle (Muller, Enderle and Westphal 2016). Nonetheless, in this study, BMR 
returned to baseline values after the final 7 days of ad-libitum energy intake (day 
29), which is in line with the findings of other studies, and therefore suggest a 
high degree of plasticity of BMR in response to changes in energy intake (Nymo 
et al. 2018; Enderle and Westphal 2016; Doucet, Pomerleau and Harper 2004). 
In addition to body mass, BMR, PAEE and step count, the study measured 
changes in systolic blood pressure, diastolic blood pressure and fasting blood 
glucose, which all showed significant improvements with the diet-induced 
intervention. Positive changes in these markers of hypertension and insulin 
sensitivity are often reported in interventions where body mass loss is at least 3% 
of the initial body mass, which significantly reduces the risk of obesity-related 
diseases and mortality (Magkos et al. 2016).  
4.1 Study Limitations 
The present study had several limitations. Firstly, the study did not control for the 
menstrual cycle, which might have impacted energy expenditure and/or energy 
intake depending on the phase the participant was in (Sims and Heather 2018). 
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For example, in the first commercial diet tailored around the menstrual cycle, the 
Menstralean diet, showed that increasing energy intake during the luteal phase 
can result in better adherence to the dietary intervention and greater body mass 
losses (Geiken et al. 2016). Secondly, the gas exchange accuracy, variability in 
room temperature, the equation used, and the protein oxidation assumptions are 
also important considerations to have when measuring and reporting BMR 
(Fernández-Verdejo, Aguirre and Galgani 2019). The conditions under which the 
indirect calorimeter was used included the use of the Weir’s equation coupled 
with the dismissed protein oxidation and testing in a laboratory where strict 
temperature control was not possible, therefore this may have affected intra-
individual variance BMR (Fernández-Verdejo, Aguirre and Galgani 2019). 
Notably, our survey found that results might have been partially skewed by 5 
participants who were not fully compliant with the study.  Due to several drop-
outs, the target number of participants was not reached. Therefore, the smaller 
sample size and uneven group sizes must be considered when interpreting the 
findings of this study (Jackson 2015). The original study design was intended to 
have identical time-frames for wearing the wrist- and hip-worn accelerometers, 
however, the latter was implemented with a 7-day delay due to firmware issues.  
The main strengths of our study were the implementation of a diet-induced ER 
that was proportional to the individual’s TDEE, and the frequent assessment of 
BMR via indirect calorimetry. This study therefore provided insights on how mild 
(3%) body mass loss can improve the measured health markers in both men and 
women. In practical applications, similar diet-induced ER can be potential 
implemented over the short term in specific contexts where rapid body mass loss 
is paramount (i.e. pre-surgery body mass loss), and without conferring 
detrimental effects in BMR and LBM. In future research, we would like to 
emphasise the potential refinement of such studies by implementing doubly-
labelled water to asses TDEE and four compartment models to asses body 
composition (DXA, MRI). 
 
4.2 Conclusions 
The present study demonstrates that 7 days of diet-induced ER at 50% of TDEE 
can translate in favourable changes in body mass, body composition, blood 
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fasting glucose, systolic blood pressure and diastolic blood pressure in 
overweight and obese adults. These rapid changes occurred concomitantly and 
in the absence of significant detrimental effects in BMR, PAEE and step count in 
both men and women.  Findings suggest that men may also be more likely to 






5.1 Compliance survey 
Q1 - Prior to assessments of basal metabolic rate, did you consume 
food/caffeine/nicotine? 
A1 – Yes. 
A2 – No. 
A3 – I do not remember.  
 
Q2 - If the answer to the previous question was YES, do you remember which 
study day was that? (Multiple choice) 
A1 – Study day 1. 
A2 – Study day 8. 
A3 – Study day 15. 
A4 – Study day 22. 
A5 – Study day 29. 
A6 – I do not remember 
 
Q3 - During the 7-day diet intervention, did you manage to finish all of your 
liquid diet? 
A1 – Yes. 
A2 – No. 
A3 – I do not remember. 
 
Q4 - During the 7-day diet phase of the study, did you consume any other 
caloric food/beverage outside of the liquid diet? 
A1 – Yes. 
A2 – No. 




5.3 Participant information sheet 
 
 
PARTICIPANT INFORMATION SHEET 
 
 
Research Title: Effect of dieting on energy expenditure in overweight and 
obese adults. 
 
Research Aim:  
The aim of this study is to clarify if losing weight through dieting has an effect on 
different types of energy expenditure and if sex plays a role in this. Some evidence 
suggests that attempting weight loss through diet may lead to compensatory effect on 





You have been invited to take part in this study because you fulfil the following 
criteria: BMI ≥ 25 and ≤ 40, aged between 18 and 40 years, untrained (i.e. not engaging 
in any structured exercise) and with no chronic disease. 
 
2. What is the purpose of the study? 
The purpose of this study is to examine the effect that initial diet-induced weight loss 
has on different types of energy expenditure and determine if there are differences 
between men and women. 
 
3. Do I have to take part? 
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No, you do not have to take part. It is up to you to decide if you would like to volunteer 
as a participant in this study. In addition, you can withdraw from the study at any point 
without needing to provide any explanation. 
 
4.  What will happen to me if I take part? 
If you take part in this study, you will be asked to carry on with your normal life for 3 
weeks and change your diet for one week. In total, the study will involve five morning 
visits to the laboratory over a 28-day period. You will be asked to fast for at least 10 
hours and refrain from smoking for at least 2 hours before the visit. During these visits 
we will measure your height, body mass, blood pressure, resting heart rate, blood 
glucose and your energy expenditure at rest. The latter test will require you to lay on 
your back in a comfortable position, stay in a silent environment for 30 minutes while 
wearing a silicone mask for gas analysis. Following this measurement, an activity 
tracker will be given to you to be worn on your left or right wrist throughout the whole 
period of this investigation (i.e. 28 days). This device is water and dust resistant, and it 
should be worn throughout the day to estimate your energy expenditure. You will also 
be provided with 7-day food and physical activity diaries to complete during each 
week. Collectively, each visit will take approximately 45 minutes of your time. On the 
third visit to the lab, you will receive a very-low liquid-based energy diet for you to 
follow for 7 days (i.e. you will only follow this diet from day 15 to day 21 of the study). 
The liquid diet will provide 50% of your energy needs and should therefore induce 




5. What are the possible risks of taking part? 
The risks associated with this study are the same as if you were undertaking any other 
substantial change to your diet. These include potentially experiencing constipation or 
diarrhoea. However, due to the short-time of this diet (i.e. 7-days duration) the risks of 
these occurring are low. 
 
6. What happens when the research study stops? 
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You will be allowed to see your results, if you wish to do so. You will also be able to 
request to see the results of the entire study after this has been completed and 
written up (If that is the case please ensure you send an e-mail to the researcher 
requesting this). It is expected that results will be published in a scientific journal. Any 
presented data will be anonymous. 
 
7. What if there is a problem? 
If there is any question, doubt or problem regarding any step of the study, ask the 
investigator for additional explanation or clarification. If matter is still not dealt 
satisfactorily you should contact the research supervisor.   
 
This completes Part 1 of the Information Sheet.  If the information in Part 1 has 
interested you and you are considering participation, please continue to read the 
additional information in Part 2 before making any decision. 
PART 2 
 
8. What will happen if I don’t want to carry on with the study? 
If you do not wish to continue with the study, you can withdraw at any time without 
having to give a reason. 
 
9. Will my part in this study be kept confidential? 
Yes, any information will be kept confidential. Furthermore, to ensure anonymity and 
confidentiality, data will not associated with a non-identifiable code and be stored on a 
password-protected file on a protected University network server. Due to university’s 
regulation, data will be kept for 10 years. 
 
10.  What will happen to the results of this study? 
The results of this study will be used for a masters research project and it is expected 
that it will also  get published in a scientific journal and/or presented at a scientific 
conference. In all cases, presented data will be anonymous. 
 
11. Who is organising and funding this study? 
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This study is led by the Abertay University and no external funding body is associated. 
 
12. Contact for further information 
If you have any question regarding this study, do not hesitate and contact the 
investigator Matevz Arcon (email: 1401312@abertaty.ac.uk) or the supervisor Joel 
Rocha (email: j.rocha@abertay.ac.uk). 
 
This project has been reviewed and approved by the Research Ethics Committee of 











Research title: Effect of dieting on energy expenditure in overweight and obese adults. 
The purpose and expected process of this study have been explained to me.  I understand that 
this study is designed to further scientific knowledge and that Abertay University has 
approved all procedures. 
 
□ I confirm that I have read and understand the participant information sheet provided. 
 
□ I have had the opportunity to consider the information, ask questions about my 
participation and have had these answered satisfactorily. 
 
□ I understand that my participation is voluntary and that I can stop taking part at any 
time without giving reason. 
 
□ I also understand that if this happens, my relationship(s) with the investigator and 
Abertay University and my legal rights will not be affected. 
 
□ I understand that my information will be used for reporting purposes but I will not be 
identified. 
 
□ I understand that researchers are obliged to retain research data for up to 10 years’ 
post-publication, however your anonymised research data may be retained 
indefinitely (e.g., so that researchers engage in open practice and other researchers 
can access their data to confirm the conclusions of published work). Researchers retain 
consent forms for as long as we continue to hold information about the participant 
and for 10 years for published research (including Research Degree thesis). 
 
□ I agree to participate in this 28-day study conducted by Matevz Arcon who intends to 
use my data for further examining the effect of a 7-day liquid diet on energy 
expenditure in overweight and obese adults. 
 
 
Participant Name:  ___________________________________________ 
 








Person taking consent: ___________________________________________ 
 
Signature:   ___________________________________________ 
 




5.5 Screening questionnaire 
SCREENING QUESTIONNAIRE.  Participant No……
YES NO
Q1.                                                                                                             HAS A DOCTOR OR NURSE EVER TOLD YOU THAT YOU HAVE HIGH BLOOD 
PRESSURE?  IF YES GIVE SOME DETAILS
Q2.                                                                                                       HAVE YOU HAD ANY HISTORY OF HEART TROUBLE?  IF YES GIVE SOME 
DETAILS
Q3. DO YOU SUFFER FROM ASTHMA?
Q4. DO YOU SUFFER FROM A WHEEZY CHEST?
Q5. DO YOU FREQUENTLY HAVE PAINS IN YOUR HEART OR CHEST?
Q6. DO YOU FREQUENTLY FEEL FAINT OR HAVE SPELLS OF DIZZINESS?
Q7. HAS A DOCTOR TOLD YOU THAT YOU HAVE A BONE OR JOINT PROBLEM 
WHICH COULD BE MADE WORSE BY EXERCISE?
Q8. DO YOU HAVE ANY PHYSICAL DISABILITIES OF ANY KIND?  IF YES GIVE 
DETAILS
Q9. ARE YOU, OR DO YOU THINK YOU MIGHT BE, PREGNANT AT THE MOMENT?  IF 
YES, HOW MANY WEEKS?
Q10 HAVE YOU BEEN IN HOSPITAL IN THE LAST TWO YEARS?  IF YES GIVE REASON 
AND OUTCOME
Q11 HAVE YOU HAD ANY OPERATIONS OR MAJOR ILLNESS IN THE PAST 6 
MONTHS?  IF YES GIVE DETAILS
Q12 ARE YOU UNDERGOING TREATMENT OR HAVING ANY REGULAR CHECKS 
MADE FOR ANYTHING AT THE DOCTORS, OR A HOSPITAL OR A CLINIC AT THE 
MOMENT?  IF YES GIVE SOME DETAILS
Q13 ARE YOU TAKING MEDICATION REGULARLY?  IF YES GIVE DETAILS, 
INCLUDING NAME OF MEDICATION














5.6 Food declaration 
Food Declaration 
 
The following label includes nutritional values and ingredients of each flavour for 
the VLCD Meal Replacement Shake. Please, read carefully the ingredients of 
each flavour to avoid ingestion of potential allergens. 
 
Salted caramel (nutritional values):  
Per/ Pour / Pro / Por Cada / Per 100g 51g 
Energy / Énergie / Energie / Valores Energéticos /Energia 1663 kJ/392 kcal 848 
kJ/200 kcal 
Fat/ Lipides / Fett/ Grasas / Grassi 13 g 6 . 7 g of which saturates / dont saturés 
/ davon gesättigt /de las cuales saturadas / di cui saturi 6 . 2 g 3 . 1 g 
Carbohydrates / Glucides / Kohlenhydrate /Hidratos de Carbono / Carboidrati 
34 g 17 g of which sugars / dont sucres / davon Zucker/ de los cuales azúcares 
/ di cui zuccheri 27 g 14 g 
Fibre / Fibres alimentaires / Ballaststoffe / Fibra alimentaria / Fibre 8 . 0 g 4 . 1 g 
Protein / Proteines / Protein / Proteínas / Proteine 34 g 18 g 
Salt/ Sel / Salz / Sal / Sale 1 . 8 g 0 . 90 g 
Vitamin A / Vitamine A / Vitamin A / 
Vitamina A / Vitamina A 550µg RE (69% RI*) 280mg (35%RI*) 
Vitamin D / Vitamine D / Vitamin D / Vitamina D / Vitamina D 4 . 3µg (86% RI*) 
2 . 2µg (44% RI*) 
Vitamin E / Vitamine E / Vitamin E / 
Vitamina E / Vitamina E 9 . 4mg a-TE (78% RI*)4 . 8mg a-TE (40%RI*) 
Vitamin K / Vitamine K / Vitamin K / 
Vitamina K / Vitamina K 58µg (77% RI*) 30µg (40% RI*) 
Vitamin C / Vitamine C / Vitamin C / 
Vitamina C / Vitamina C 64mg (81% RI*) 33mg (45% RI*) 
Thiamin / Thiamine / Thiamin / 
Tiamina / Tiamina 0 . 9mg (82% RI*) 0 . 5mg (45 % RI*) 
Riboflavin / Riboflavine / Riboflavin / 
Riboflavina / Riboflavina 1 . 9mg (136% RI*) 1 . 0mg (71% RI*) 
Niacin / Niacine / Niacin / 
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Niacina / Niacina 15mg NE (94% RI*) 7 . 4mg NE (46% RI*) 
Vitamin B6 / Vitamine B6 / Vitamin B6 / 
Vitamina B6 / Vitamina B6 1 . 3mg (93% RI*) 0 . 7mg (50% RI*) 
Per/ Pour / Pro / Por Cada / Per 100g 51g 
Folic Acid / Acide Folique / Folsäure / 
Ácido Fólico / Acido Folico 166µg (93% RI*) 84 . 6µg (42% RI*) 
Vitamin B12 / Vitamine B12 / Vitamin B12 / 
Vitamina B12 / Vitamina B12 2 . 5µg (100% RI*) 1 . 3µg (52% RI*) 
Biotin / Biotine / Biotin / Biotina / Biotina 41µg (82% RI*) 21µg (42% RI*) 
Pantothenic Acid / Acide Pantothénique / 
Pantothensäure / Ácido Pantoténico / Acido Pantotenico 5 . 2mg (87% RI*) 2 . 
6mg (43% RI*) 
Potassium / Potassium / Kalium / 
Potasio / Potassio 2057mg (102% RI*) 1049mg (52% RI*) 
Chloride / Chlorure / Chloride / Cloruro / Cloruro 1016mg (127% RI*) 518mg 
(65% RI*) 
Calcium / Calcium / Kalzium / Calcio / Calcio 758mg (95% RI*) 387mg (48% 
RI*) 
Phosphorous / Phosphore / Phosphor / 
Fósforo / Fosforo 523mg (75% RI*) 267mg (38% RI*) 
Magnesium / Magnesium / Magnesium / 
Magnesio / Magnesio 265mg (70%RI*) 135mg (36%RI*) 
Iron / Fer / Eisen / Hierro / Ferro 15mg (107%RI*) 7 . 4mg (53%RI*) 
Zinc / Zinc / Zink / Zinc / Zinco 8 . 7mg (87%RI*) 4 . 4mg(44%RI*) 
Copper / Cuivre / Kupfer/ Cobre / Rame 0 . 7mg (70%RI*) 0 . 4mg (40%RI*) 
Manganese/ Manganèse / Mangan / 
Manganeso / Manganese 1 . 6mg (80%RI*) 0 . 8mg (40%RI*) 
Fluoride / Fluor / Fluorid / Floruro / Fluoruro 2 . 8mg (80%RI*) 1 . 4mg (40%RI*) 
Selenium / Sélénium / Sélénium / Selenio / Selenio 47µg (85%RI*) 
24µg(43%RI*) 
Chromium / Chrome / Chrom / Cromo / Cromo 31µg (78%RI*) 16µg(40%RI*) 
Molybdenum / Molybdène / Molybden / 
Molibdeno / Molibdeno 53µg (107%RI*) 27µg (54%RI*) 




Salted Caramel (Ingredients): 
Skimmed Milk Powder (41%), Dietary Fat Concentrate (Refined Coconut Oil, 
Refined Soybean Oil, Milk Proteins, Whey Powder (Milk), Maltodextrin, 
Emulsifier (Lecithins [Contains Soy]), Stabiliser (Triphosphates), Antioxidants 
(Fatty Acid Esters of Ascorbic Acid, Alpha-Tocopherol), Anti Caking Agent 
(Calcium Phosphates), Whey Protein Concentrate (Milk, Soy Protein Isolate 
(Soy]) , Flavouring, Inulin Powder, Potassium Citrate, Thickener (Xanthan Gum) 
, Di Potassium Phosphate Powder, Salt, Calcium Chloride, Colour (E150c), 
Sweetener (Sucralose), Vitamin and Mineral Premix (Folic Acid, Vitamin C, 
Niacin, Iron, Vitamin E, Zinc, Pantothenic Acid, Fluoride, Manganese, Vitamin 
B6, Vitamin B2, Vitamin B1, Copper, Vitamin A, Iodine, Vitamin K, Selenium, 
Molybdenum, Biotin, Chromium, Vitamin D, Vitamin B12), Magnesium Oxide. 
 
Banana (Nutritional Values): 
Per/ Pour / Pro / Por Cada / Per 100g 51g 
Energy / Énergie / Energie / Valores Energéticos /Energia 1663 kJ/392 kcal 848 
kJ/200 kcal 
Fat/ Lipides / Fett/ Grasas / Grassi 13 g 6 . 7 g of which saturates / dont saturés 
/ davon gesättigt / de las cuales saturadas / di cui saturi 6 . 2 g 3 . 1 g 
Carbohydrates / Glucides / Kohlenhydrate /Hidratos de Carbono / Carboidrati 
34 g 17 g of which sugars / dont sucres / davon Zucker/de los cuales azúcares / 
di cui zuccheri 27 g 14 g 
Fibre / Fibres alimentaires / Ballaststoffe / Fibra alimentaria / Fibre 8 . 0 g 4 . 1 g 
Protein / Proteines / Protein / Proteínas / Proteine 34 g 18 g 
Salt/ Sel / Salz / Sal / Sale 1 . 8 g 0 . 90 g 
Vitamin A / Vitamine A / Vitamin A / 
Vitamina A / Vitamina A 550µg RE (69% RI*) 280mg (35%RI*) 
Vitamin D / Vitamine D / Vitamin D / Vitamina D / Vitamina D 4 . 3µg (86% RI*) 
2 . 2µg (44% RI*) 
Vitamin E / Vitamine E / Vitamin E / 
Vitamina E / Vitamina E 9 . 4mg a-TE (78% RI*)4 . 8mg a-TE (40%RI*) 
Vitamin K / Vitamine K / Vitamin K / 
Vitamina K / Vitamina K 58µg (77% RI*) 30µg (40% RI*) 
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Vitamin C / Vitamine C / Vitamin C / 
Vitamina C / Vitamina C 64mg (81% RI*) 33mg (45% RI*) 
Thiamin / Thiamine / Thiamin / 
Tiamina / Tiamina 0 . 9mg (82% RI*) 0 . 5mg (45 % RI*) 
Riboflavin / Riboflavine / Riboflavin / 
Riboflavina / Riboflavina 1 . 9mg (136% RI*) 1 . 0mg (71% RI*) 
Niacin / Niacine / Niacin / 
Niacina / Niacina 15mg NE (94% RI*) 7 . 4mg NE (46% RI*) 
Vitamin B6 / Vitamine B6 / Vitamin B6 / 
Vitamina B6 / Vitamina B6 1 . 3mg (93% RI*) 0 . 7mg (50% RI*) 
Per/ Pour / Pro / Por Cada / Per 100g 51g 
Folic Acid / Acide Folique / Folsäure / 
Ácido Fólico / Acido Folico 166µg (93% RI*) 84 . 6µg (42% RI*) 
Vitamin B12 / Vitamine B12 / Vitamin B12 / 
Vitamina B12 / Vitamina B12 2 . 5µg (100% RI*) 1 . 3µg (52% RI*) 
Biotin / Biotine / Biotin / Biotina / Biotina 41µg (82% RI*) 21µg (42% RI*) 
Pantothenic Acid / Acide Pantothénique / 
Pantothensäure / Ácido Pantoténico / Acido Pantotenico 5 . 2mg (87% RI*) 2 . 
6mg (43% RI*) 
Potassium / Potassium / Kalium / 
Potasio / Potassio 2057mg (102% RI*) 1049mg (52% RI*) 
Chloride / Chlorure / Chloride / Cloruro / Cloruro 1016mg (127% RI*) 518mg 
(65% RI*) 
Calcium / Calcium / Kalzium / Calcio / Calcio 758mg (95% RI*) 387mg (48% 
RI*) 
Phosphorous / Phosphore / Phosphor / 
Fósforo / Fosforo 523mg (75% RI*) 267mg (38% RI*) 
Magnesium / Magnesium / Magnesium / 
Magnesio / Magnesio 265mg (70%RI*) 135mg (36%RI*) 
Iron / Fer / Eisen / Hierro / Ferro 15mg (107%RI*) 7 . 4mg (53%RI*) 
Zinc / Zinc / Zink / Zinc / Zinco 8 . 7mg (87%RI*) 4 . 4mg(44%RI*) 
Copper / Cuivre / Kupfer/ Cobre / Rame 0 . 7mg (70%RI*) 0 . 4mg (40%RI*) 
Manganese/ Manganèse / Mangan / 
Manganeso / Manganese 1 . 6mg (80%RI*) 0 . 8mg (40%RI*) 
 
40 
Fluoride / Fluor / Fluorid / Floruro / Fluoruro 2 . 8mg (80%RI*) 1 . 4mg (40%RI*) 
Selenium / Sélénium / Sélénium / Selenio / Selenio 47µg (85%RI*) 
24µg(43%RI*) 
Chromium / Chrome / Chrom / Cromo / Cromo 31µg (78%RI*) 16µg(40%RI*) 
Molybdenum / Molybdène / Molybden / 
Molibdeno / Molibdeno 53µg (107%RI*) 27µg (54%RI*) 
Iodine / Iode / Jod / Yodo / Iodio 114µg (76%RI*) 58µg(39%RI* 
 
Banana (Ingredients) :  
Skimmed Milk Powder (41%), Dietary Fat Concentrate (Refined Coconut Oil, 
Refined Soybean Oil, Milk Proteins, Whey Powder (Milk), Maltodextrin, 
Emulsifier (Lecithins [Contains Soy]), Stabiliser (Triphosphates), Antioxidants 
(Fatty Acid Esters of Ascorbic Acid, Alpha-Tocopherol), Anti Caking Agent 
(Calcium Phosphates), Whey Protein Concentrate (Milk, Soy Protein Isolate 
(Soy]), Flavouring, Inulin Powder, Potassium Citrate, Thickener (Xanthan Gum) 
, Di Potassium Phosphate Powder, Salt, Calcium Chloride, Colour (Curcumin), 
Sweetener (Sucralose), Vitamin and Mineral Premix (Folic Acid, Vitamin C, 
Niacin, Iron, Vitamin E, Zinc, Pantothenic Acid, Fluoride, Manganese, Vitamin 
B6, Vitamin B2, Vitamin B1, Copper, Vitamin A, Iodine, Vitamin K, Selenium, 
Molybdenum, Biotin, Chromium, Vitamin D, Vitamin B12), Magnesium Oxide. 
 
Chocolate (nutritional values): 
Per/ Pour / Pro / Por Cada / Per 100g 51g 
Energy / Énergie / Energie / Valores Energéticos /Energia 1662 kJ/392 kcal 848 
kJ/200 kcal 
Fat/ Lipides / Fett/ Grasas / Grassi 13 g 6 . 7 g of which saturates / dont saturés 
/ davon gesättigt / de las cuales saturadas / di cui saturi 6 . 3 g 3 . 2 g 
Carbohydrates / Glucides / Kohlenhydrate /Hidratos de Carbono / Carboidrati 
34 g 17 g of which sugars / dont sucres / davon Zucker/de los cuales azúcares / 
di cui zuccheri 28 g 14 g 
Fibre / Fibres alimentaires / Ballaststoffe / Fibra alimentaria / Fibre 8 . 5 g 4 . 3 g 
Protein / Proteines / Protein / Proteínas / Proteine 34 g 17 g 
Salt/ Sel / Salz / Sal / Sale 1 . 8 g 0 . 90 g 
Vitamin A / Vitamine A / Vitamin A / 
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Vitamina A / Vitamina A 550µg RE (69% RI*) 280mg (35%RI*) 
Vitamin D / Vitamine D / Vitamin D / Vitamina D / Vitamina D 4 . 3µg (86% RI*) 
2 . 2µg (44% RI*) 
Vitamin E / Vitamine E / Vitamin E / 
Vitamina E / Vitamina E 9 . 4mg a-TE (78% RI*)4 . 8mg a-TE (40%RI*) 
Vitamin K / Vitamine K / Vitamin K / 
Vitamina K / Vitamina K 58µg (77% RI*) 30µg (40% RI*) 
Vitamin C / Vitamine C / Vitamin C / 
Vitamina C / Vitamina C 64mg (81% RI*) 33mg (45% RI*) 
Thiamin / Thiamine / Thiamin / Tiamina / Tiamina 0 . 9mg (82% RI*) 0 . 5mg (45 
% RI*) 
Riboflavin / Riboflavine / Riboflavin / 
Riboflavina / Riboflavina 1 . 9mg (136% RI*) 1 . 0mg (71% RI*) 
Niacin / Niacine / Niacin / 
Niacina / Niacina 15mg NE (94% RI*) 7 . 4mg NE (46% RI*) 
Vitamin B6 / Vitamine B6 / Vitamin B6 / 
Vitamina B6 / Vitamina B6 1 . 3mg (93% RI*) 0 . 7mg (50% RI*) 
Per/ Pour / Pro / Por Cada / Per 100g 51g 
Folic Acid / Acide Folique / Folsäure / 
Ácido Fólico / Acido Folico 166µg (93% RI*) 84 . 6µg (42% RI*) 
Vitamin B12 / Vitamine B12 / Vitamin B12 / 
Vitamina B12 / Vitamina B12 2 . 5µg (100% RI*) 1 . 3µg (52% RI*) 
Biotin / Biotine / Biotin / Biotina / Biotina 41µg (82% RI*) 21µg (42% RI*) 
Pantothenic Acid / Acide Pantothénique / 
Pantothensäure / Ácido Pantoténico / Acido Pantotenico 5 . 2mg (87% RI*) 2 . 
6mg (43% RI*) 
Potassium / Potassium / Kalium / 
Potasio / Potassio 2057mg (102% RI*) 1049mg (52% RI*) 
Chloride / Chlorure / Chloride / Cloruro / Cloruro 1016mg (127% RI*) 518mg 
(65% RI*) 
Calcium / Calcium / Kalzium / Calcio / Calcio 758mg (95% RI*) 387mg (48% 
RI*) 
Phosphorous / Phosphore / Phosphor / 
Fósforo / Fosforo 523mg (75% RI*) 267mg (38% RI*) 
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Magnesium / Magnesium / Magnesium / 
Magnesio / Magnesio 265mg (70%RI*) 135mg (36%RI*) 
Iron / Fer / Eisen / Hierro / Ferro 15mg (107%RI*) 7 . 4mg (53%RI*) 
Zinc / Zinc / Zink / Zinc / Zinco 8 . 7mg (87%RI*) 4 . 4mg(44%RI*) 
Copper / Cuivre / Kupfer/ Cobre / Rame 0 . 7mg (70%RI*) 0 . 4mg (40%RI*) 
Manganese/ Manganèse / Mangan / 
Manganeso / Manganese 1 . 6mg (80%RI*) 0 . 8mg (40%RI*) 
Fluoride / Fluor / Fluorid / Floruro / Fluoruro 2 . 8mg (80%RI*) 1 . 4mg (40%RI*) 
Selenium / Sélénium / Sélénium / Selenio / Selenio 47µg (85%RI*) 
24µg(43%RI*) 
Chromium / Chrome / Chrom / Cromo / Cromo 31µg (78%RI*) 16µg(40%RI*) 
Molybdenum / Molybdène / Molybden / 
Molibdeno / Molibdeno 53µg (107%RI*) 27µg (54%RI*) 
Iodine / Iode / Jod / Yodo / Iodio 114µg (76%RI*) 58µg(39%RI*) 
Chocolate (Ingredients) : Skimmed Milk Powder (41%), Dietary Fat 
Concentrate (Refined Coconut Oil, Refined Soybean Oil, Milk Proteins, Whey 
Powder (Milk), Maltodextrin, Emulsifier (Lecithins [Contains Soy]), Stabiliser 
(Triphosphates), Antioxidants (Fatty Acid Esters of Ascorbic Acid, Alpha-
Tocopherol), Anti Caking Agent (Calcium Phosphates), Whey Protein 
Concentrate (Milk, Soy Protein Isolate (Soy]), Flavouring, Inulin Powder, 
Potassium Citrate, Thickener (Xanthan Gum) , Di Potassium Phosphate 
Powder, Salt, Calcium Chloride, Cocoa Powder, Sweetener (Sucralose), 
Vitamin and Mineral Premix (Folic Acid, Vitamin C, Niacin, Iron, Vitamin E, Zinc, 
Pantothenic Acid, Fluoride, Manganese, Vitamin B6, Vitamin B2, Vitamin B1, 
Copper, Vitamin A, Iodine, Vitamin K, Selenium, Molybdenum, Biotin, 
Chromium, Vitamin D, Vitamin B12), Magnesium Oxide. 
 
Strawberry (Nutritional values): 
Per/ Pour / Pro / Por Cada / Per 100g 51g 
Energy / Énergie / Energie / Valores Energéticos /Energia 1660 kJ/391 kcal 847 
kJ/199 kcal 
Fat/ Lipides / Fett/ Grasas / Grassi 13 g 6 . 7 g of which saturates / dont saturés 
/ davon gesättigt / de las cuales saturadas / di cui saturi 6 . 2 g 3 . 1 g 
Carbohydrates / Glucides / Kohlenhydrate / Hidratos de Carbono / Carboidrati 
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33 g 17 g of which sugars / dont sucres / davon Zucker/ de los cuales azúcares 
/ di cui zuccheri 27 g 14 g 
Fibre / Fibres alimentaires / Ballaststoffe / Fibra alimentaria / Fibre 8 . 1 g 4 . 1 g 
Protein / Proteines / Protein / Proteínas / Proteine 35 g 18 g 
Salt/ Sel / Salz / Sal / Sale 1 . 8 g 0 . 90 g 
Vitamin A / Vitamine A / Vitamin A / 
Vitamina A / Vitamina A 550µg RE (69% RI*) 280mg (35%RI*) 
Vitamin D / Vitamine D / Vitamin D / Vitamina D / Vitamina D 4 . 3µg (86% RI*) 
2 . 2µg (44% RI*) 
Vitamin E / Vitamine E / Vitamin E / 
Vitamina E / Vitamina E 9 . 4mg a-TE (78% RI*)4 . 8mg a-TE (40%RI*) 
Vitamin K / Vitamine K / Vitamin K / 
Vitamina K / Vitamina K 58µg (77% RI*) 30µg (40% RI*) 
Vitamin C / Vitamine C / Vitamin C / 
Vitamina C / Vitamina C 64mg (81% RI*) 33mg (45% RI*) 
Thiamin / Thiamine / Thiamin / 
Tiamina / Tiamina 0 . 9mg (82% RI*) 0 . 5mg (45 % RI*) 
Riboflavin / Riboflavine / Riboflavin / 
Riboflavina / Riboflavina 1 . 9mg (136% RI*) 1 . 0mg (71% RI*) 
Niacin / Niacine / Niacin / 
Niacina / Niacina 15mg NE (94% RI*) 7 . 4mg NE (46% RI*) 
Vitamin B6 / Vitamine B6 / Vitamin B6 / 
Vitamina B6 / Vitamina B6 1 . 3mg (93% RI*) 0 . 7mg (50% RI*) 
Per/ Pour / Pro / Por Cada / Per 100g 51g 
Folic Acid / Acide Folique / Folsäure / 
Ácido Fólico / Acido Folico 166µg (93% RI*) 84 . 6µg (42% RI*) 
Vitamin B12 / Vitamine B12 / Vitamin B12 / 
Vitamina B12 / Vitamina B12 2 . 5µg (100% RI*) 1 . 3µg (52% RI*) 
Biotin / Biotine / Biotin / Biotina / Biotina 41µg (82% RI*) 21µg (42% RI*) 
Pantothenic Acid / Acide Pantothénique / 
Pantothensäure / Ácido Pantoténico / Acido Pantotenico 5 . 2mg (87% RI*) 2 . 
6mg (43% RI*) 
Potassium / Potassium / Kalium / 
Potasio / Potassio 2057mg (102% RI*) 1049mg (52% RI*) 
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Chloride / Chlorure / Chloride / Cloruro / Cloruro 1016mg (127% RI*) 518mg 
(65% RI*) 
Calcium / Calcium / Kalzium / Calcio / Calcio 758mg (95% RI*) 387mg (48% 
RI*) 
Phosphorous / Phosphore / Phosphor / 
Fósforo / Fosforo 523mg (75% RI*) 267mg (38% RI*) 
Magnesium / Magnesium / Magnesium / 
Magnesio / Magnesio 265mg (70%RI*) 135mg (36%RI*) 
Iron / Fer / Eisen / Hierro / Ferro 15mg (107%RI*) 7 . 4mg (53%RI*) 
Zinc / Zinc / Zink / Zinc / Zinco 8 . 7mg (87%RI*) 4 . 4mg(44%RI*) 
Copper / Cuivre / Kupfer/ Cobre / Rame 0 . 7mg (70%RI*) 0 . 4mg (40%RI*) 
Manganese/ Manganèse / Mangan / 
Manganeso / Manganese 1 . 6mg (80%RI*) 0 . 8mg (40%RI*) 
Fluoride / Fluor / Fluorid / Floruro / Fluoruro 2 . 8mg (80%RI*) 1 . 4mg (40%RI*) 
Selenium / Sélénium / Sélénium / Selenio / Selenio 47µg (85%RI*) 
24µg(43%RI*) 
Chromium / Chrome / Chrom / Cromo / Cromo 31µg (78%RI*) 16µg(40%RI*) 
Molybdenum / Molybdène / Molybden / 
Molibdeno / Molibdeno 53µg (107%RI*) 27µg (54%RI*) 
Iodine / Iode / Jod / Yodo / Iodio 114µg (76%RI*) 58µg(39%RI*) 
 
Strawberry (Ingredients) : Skimmed Milk Powder (41%), Dietary Fat 
Concentrate (Refined Coconut Oil, Refined Soybean Oil, Milk Proteins, Whey 
Powder (Milk), Maltodextrin, Emulsifier (Lecithins [Contains Soy]), Stabiliser 
(Triphosphates), Antioxidants (Fatty Acid Esters of Ascorbic Acid, Alpha-
Tocopherol), Anti Caking Agent (Calcium Phosphates), Whey Protein 
Concentrate (Milk, Soy Protein Isolate (Soy]), Flavouring, Inulin Powder, 
Potassium Citrate, Thickener (Xanthan Gum) , Di Potassium Phosphate 
Powder, Salt, Calcium Chloride, Colour (Beetroot Powder), Sweetener 
(Sucralose), Vitamin and Mineral Premix (Folic Acid, Vitamin C, Niacin, Iron, 
Vitamin E, Zinc, Pantothenic Acid, Fluoride, Manganese, Vitamin B6, Vitamin 
B2, Vitamin B1, Copper, Vitamin A, Iodine, Vitamin K, Selenium, Molybdenum, 




Vanilla (nutritional values): 
Per/ Pour / Pro / Por Cada / Per 100g 51g 
Energy / Énergie / Energie / Valores Energéticos /Energia 1663 kJ/392 kcal 848 
kJ/200 kcal 
Fat/ Lipides / Fett/ Grasas / Grassi 13 g 6 . 7 g of which saturates / dont saturés 
/ davon gesättigt / de las cuales saturadas / di cui saturi 6 . 2 g 3 . 1 g 
Carbohydrates / Glucides / Kohlenhydrate / Hidratos de Carbono / Carboidrati 
34 g 17 g of which sugars / dont sucres / davon Zucker/ de los cuales azúcares 
/ di cui zuccheri 28 g 14 g 
Fibre / Fibres alimentaires / Ballaststoffe / Fibra alimentaria / Fibre 8 . 0 g 4 . 1 g 
Protein / Proteines / Protein / Proteínas / Proteine 34 g 18 g 
Salt/ Sel / Salz / Sal / Sale 1 . 8 g 0 . 90 g 
Vitamin A / Vitamine A / Vitamin A / 
Vitamina A / Vitamina A 550µg RE (69% RI*) 280mg (35%RI*) 
Vitamin D / Vitamine D / Vitamin D / Vitamina D / Vitamina D 4 . 3µg (86% RI*) 
2 . 2µg (44% RI*) 
Vitamin E / Vitamine E / Vitamin E / 
Vitamina E / Vitamina E 9 . 4mg a-TE (78% RI*)4 . 8mg a-TE (40%RI*) 
Vitamin K / Vitamine K / Vitamin K / 
Vitamina K / Vitamina K 58µg (77% RI*) 30µg (40% RI*) 
Vitamin C / Vitamine C / Vitamin C / 
Vitamina C / Vitamina C 64mg (81% RI*) 33mg (45% RI*) 
Thiamin / Thiamine / Thiamin / 
Tiamina / Tiamina 0 . 9mg (82% RI*) 0 . 5mg (45 % RI*) 
Riboflavin / Riboflavine / Riboflavin / 
Riboflavina / Riboflavina 1 . 9mg (136% RI*) 1 . 0mg (71% RI*) 
Niacin / Niacine / Niacin / 
Niacina / Niacina 15mg NE (94% RI*) 7 . 4mg NE (46% RI*) 
Vitamin B6 / Vitamine B6 / Vitamin B6 / 
Vitamina B6 / Vitamina B6 1 . 3mg (93% RI*) 0 . 7mg (50% RI*) 
Per/ Pour / Pro / Por Cada / Per 100g 51g 
Folic Acid / Acide Folique / Folsäure / 
Ácido Fólico / Acido Folico 166µg (93% RI*) 84 . 6µg (42% RI*) 
Vitamin B12 / Vitamine B12 / Vitamin B12 / 
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Vitamina B12 / Vitamina B12 2 . 5µg (100% RI*) 1 . 3µg (52% RI*) 
Biotin / Biotine / Biotin / Biotina / Biotina 41µg (82% RI*) 21µg (42% RI*) 
Pantothenic Acid / Acide Pantothénique / 
Pantothensäure / Ácido Pantoténico / Acido Pantotenico 5 . 2mg (87% RI*) 2 . 
6mg (43% RI*) 
Potassium / Potassium / Kalium / 
Potasio / Potassio 2057mg (102% RI*) 1049mg (52% RI*) 
Chloride / Chlorure / Chloride / Cloruro / Cloruro 1016mg (127% RI*) 518mg 
(65% RI*) 
Calcium / Calcium / Kalzium / Calcio / Calcio 758mg (95% RI*) 387mg (48% 
RI*) 
Phosphorous / Phosphore / Phosphor / 
Fósforo / Fosforo 523mg (75% RI*) 267mg (38% RI*) 
Magnesium / Magnesium / Magnesium / 
Magnesio / Magnesio 265mg (70%RI*) 135mg (36%RI*) 
Iron / Fer / Eisen / Hierro / Ferro 15mg (107%RI*) 7 . 4mg (53%RI*) 
Zinc / Zinc / Zink / Zinc / Zinco 8 . 7mg (87%RI*) 4 . 4mg(44%RI*) 
Copper / Cuivre / Kupfer/ Cobre / Rame 0 . 7mg (70%RI*) 0 . 4mg (40%RI*) 
Manganese/ Manganèse / Mangan / 
Manganeso / Manganese 1 . 6mg (80%RI*) 0 . 8mg (40%RI*) 
Fluoride / Fluor / Fluorid / Floruro / Fluoruro 2 . 8mg (80%RI*) 1 . 4mg (40%RI*) 
Selenium / Sélénium / Sélénium / Selenio / Selenio 47µg (85%RI*) 
24µg(43%RI*) 
Chromium / Chrome / Chrom / Cromo / Cromo 31µg (78%RI*) 16µg(40%RI*) 
Molybdenum / Molybdène / Molybden / 
Molibdeno / Molibdeno 53µg (107%RI*) 27µg (54%RI*) 
Iodine / Iode / Jod / Yodo / Iodio 114µg (76%RI*) 58µg(39%RI* 
 
Vanilla Flavour(ingredients): Skimmed Milk Powder (41%), Dietary Fat 
Concentrate (Refined Coconut Oil, Refined Soybean Oil, Milk Proteins, Whey 
Powder (Milk), Maltodextrin, Emulsifier (Lecithins [Contains Soy]), Stabiliser 
(Triphosphates), Antioxidants (Fatty Acid Esters of Ascorbic Acid, Alpha-
Tocopherol), Anti Caking Agent (Calcium Phosphates), Whey Protein 
Concentrate (Milk, Soy Protein Isolate (Soy]), Flavouring, Inulin Powder, 
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Potassium Citrate, Thickener (Xanthan Gum) , Di Potassium Phosphate 
Powder, Salt, Calcium Chloride, Sweetener (Sucralose), Vitamin and Mineral 
Premix (Folic Acid, Vitamin C, Niacin, Iron, Vitamin E, Zinc, Pantothenic Acid, 
Fluoride, Manganese, Vitamin B6, Vitamin B2, Vitamin B1, Copper, Vitamin A, 
Iodine, Vitamin K, Selenium, Molybdenum, Biotin, Chromium, Vitamin D, 




I have carefully read the nutritional values and ingredient lists for each 
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